Medical News

RSS

Researchers develop new RNA molecule approach to kill cancer cells

Researchers at the California Institute of Technology (Caltech) have engineered a fundamentally new approach to killing cancer cells. The process developed by Niles Pierce, associate professor of applied and computational mathematics and bioengineering at Caltech, and his colleagues uses small RNA molecules that can be programmed to attack only specific cancer cells then, by changing shape, those molecules cause the cancer cells to self destruct.

8 Sep 2010

Biomoda joins Saccomanno Research Institute to advance CyPath technology for cancer detection

Cancer diagnostics company Biomoda, Inc. is working with the Saccomanno Research Institute to advance Biomoda's patented system for measuring the photon emission rate of CyPath-stained cells to detect early-stage lung cancer.

8 Sep 2010

Yeast can be simple model to study molecular basis of Parkinson’s disease

Yeast could be a powerful ally in the discovery of new therapeutic drugs to treat Parkinson's disease says a scientist presenting his work at the Society for General Microbiology's autumn meeting in Nottingham today.

8 Sep 2010

Air Techniques introduces patented antimicrobial coating to ensure safe air

Air Techniques, Inc., a leading manufacturer of dental equipment for nearly five decades, introduces a Patented "Antimicrobial Coating" to its complete line of AirStar Dental Compressors.

8 Sep 2010

Watson Laboratories receives FDA approval for Zarah tablets

Watson Pharmaceuticals, Inc., today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application for Zarah (drospirenone and ethinyl estradiol tablets) 3 mg/0.03 mg, the generic equivalent to Bayer's Yasmin.

7 Sep 2010

AHRQ releases free evidence-based guides for eight health conditions

HHS' Agency for Healthcare Research and Quality today released a series of free evidence-based guides designed to help Spanish speakers understand and compare the risks, benefits and side effects of treatments for eight health conditions.

7 Sep 2010

UCSF scientists to receive two grants for personalized medicine research

UCSF scientists will receive two grants totaling $15.1 million over the next five years to expand their research into how genes affect an individual's response to medication and to strengthen a global network of researchers involved in these efforts.

7 Sep 2010

Schizophrenia linked to lack of Vitamin D: study

Researchers at Queensland Brain Institute have found that babies born with low vitamin D levels are twice as likely to develop schizophrenia later in life. This could mean that it may be possible to prevent schizophrenia, which affects almost 200,000 Australians.

7 Sep 2010

Morning sickness treatment still elusive: Review

According to experts we are nowhere near establishing safe and effective ways to treat morning sickness. Since the Thalidomide disaster in 1960’s that led to severe birth defects in the infants, this area of research is scary and less explored by many researchers. Despite its name, the vomiting and nausea of morning sickness can occur at any time of the day and affect about half of pregnant women. Between 70% and 85% of women will experience nausea during pregnancy, with about half suffering vomiting. Around 2% will experience it so badly they need to be hospitalised.

7 Sep 2010

Bligh explains plans for asset sales

According to Queensland Premier Anna Bligh, new developments are on the horizon only if her Government continues with the sell off of $15 billion of public assets. She revealed this in her annual State of the State address at the mid point of her term in Government yesterday while reviewing the past 18 months and forecasting the next stage of the state's development.

7 Sep 2010

Ahead of U.N. MDG Summit, media outlets examine various aspects of goals

Ahead of the U.N. Millennium Development Goals (MDGs) Summit on September 20-22, the media examines different aspects of the MDGs.

7 Sep 2010

Study: Malpractice costs $55.6 billion annually, most in defensive medicine

An analysis by the journal Health Affairs has found that $55.6 billion, 2.4 percent of all annual health spending, is spent on medical malpractice, reports Modern Healthcare. "The estimate includes defensive-medicine activities, such as ordering tests or treatments ... which alone costs an estimated $45.6 billion per year, the study found.

7 Sep 2010

World Water Week kicks off with a focus on pollution, quality

A group of over 2,500 leading water experts from 130 countries gathered in Stockholm on Sunday to kick off World Water Week, where they will focus on "increasing water pollution and dwindling water quality around the globe," Agence France-Presse reports (Larson, 9/5).

7 Sep 2010

State Roundup: Some premiums soar in Washington State; Building boom for Denver hospitals; Looking for uninsured kids

The Seattle Times: "Whopping rate increases are coming soon for many people with individual health-insurance policies. Most insurers offering individual policies in the state have asked for and been granted rate increases, effective Oct. 1, according to the state's insurance commissioner. Regence BlueShield's rate increase — an average 16.5 percent — was one of the highest.

7 Sep 2010

Short sleep duration associated with elevated risk of diabetes, heart disease and stroke

People who sleep less than six hours a night may be three times more likely to develop a condition which leads to diabetes and heart disease, according to researchers at the University of Warwick.

7 Sep 2010

OpEds: Health costs and new law; Penn. doctor supply; Anesthesiologists vs. nurses

Some sort of Medicare-for-all program remains the only equitable way that every American can be provided with adequate and affordable coverage. This wouldn't be socialized medicine and it wouldn't be state-run healthcare (David Lazarus, 9/7).

7 Sep 2010

Also in Global Health News: India's antibiotic use; Abstinence curriculum in China; Child, maternal health in India; Plumpy'nut; PEPFAR funds to Uganda

"The health ministry has formed a committee to frame a policy for antibiotic use, following an uproar over a Lancet study that traced a drug-resistant bacterial superbug's origins to India," LiveMint.com reports. The panel will also look into the "excessive use of antibiotics among Indians," partly fueled by self-medication, that has increased resistance to the drugs. The article notes that the Indian government "rejected the findings of the report" but has "taken note of a lack of policy on antibiotics" (Pandeya, 9/3).

7 Sep 2010

Teleflex partners with Access Scientific to distribute The PICC WAND vascular access device

Teleflex has partnered with Access Scientific Incorporated, San Diego, California to become the U.S. distributor of The PICC WAND™ Safety Introducer with ARROW® peelable sheath. This new, all- in-one vascular access device provides clinicians a faster, safer, simpler way to insert a peel away sheath for PICC or Midline catheter placements.

7 Sep 2010

Welch Allyn to introduce new EHR Preparation and Selection program to ASGE members

Welch Allyn, a leading global manufacturer of frontline medical products and solutions, today announced a strategic partnership with the American Society for Gastrointestinal Endoscopy (ASGE) that will offer the more than 11,000 members of this international organization a unique service designed to ease the process of selecting and preparing for an electronic health record (EHR) system. ASGE promotes the highest standards for endoscopic training and practice, fosters endoscopic research and is the foremost resource for endoscopic education.

7 Sep 2010

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Teleflex Incorporated today announced that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the company's ArrowEVOLUTION™ PICC with Chlorag+ard™ technology, a peripherally inserted central catheter with a Chlorhexedine-based solution that has been chemically-bonded into the surface of the catheter both intra- and extralumenally. Teleflex will launch the product for general availability in the United States in the fourth quarter.

7 Sep 2010

Medical News

Researchers develop new RNA molecule approach to kill cancer cells

Biomoda joins Saccomanno Research Institute to advance CyPath technology for cancer detection

Yeast can be simple model to study molecular basis of Parkinson’s disease

Air Techniques introduces patented antimicrobial coating to ensure safe air

Watson Laboratories receives FDA approval for Zarah tablets

AHRQ releases free evidence-based guides for eight health conditions

UCSF scientists to receive two grants for personalized medicine research

Schizophrenia linked to lack of Vitamin D: study

Morning sickness treatment still elusive: Review

Bligh explains plans for asset sales

Ahead of U.N. MDG Summit, media outlets examine various aspects of goals

Study: Malpractice costs $55.6 billion annually, most in defensive medicine

World Water Week kicks off with a focus on pollution, quality

State Roundup: Some premiums soar in Washington State; Building boom for Denver hospitals; Looking for uninsured kids

Short sleep duration associated with elevated risk of diabetes, heart disease and stroke

OpEds: Health costs and new law; Penn. doctor supply; Anesthesiologists vs. nurses

Also in Global Health News: India's antibiotic use; Abstinence curriculum in China; Child, maternal health in India; Plumpy'nut; PEPFAR funds to Uganda

Teleflex partners with Access Scientific to distribute The PICC WAND vascular access device

Welch Allyn to introduce new EHR Preparation and Selection program to ASGE members

FDA grants Teleflex 510(k) clearance for ArrowEVOLUTION PICC with Chlorag+ard technology

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News